Key result
Inoculation with a high dose of attenuated Borna disease virus (10^5-10^6 TCID50) protected rats against clinical disease and virulent challenge, unlike low doses which caused severe encephalitis.
Why the study?
The pathogenesis of Borna disease required further investigation.
May inform dose-optimized attenuated-virus vaccines in animals; leaves open translation and safety in other species.
Borna disease is a chronic neurological disease caused by an enveloped negative-strand RNA virus (BDV). Experimental disease can be reproduced in rats with brain homogenates derived from infected animals or with virus derived from infected cells in culture. The virus replicates in cultured cells without evidence of cytopathic effect or production of significant levels of cell-free virus. Borna disease is caused by an immunopathological response to viral infection of neural cells. To further investigate the pathogenesis of Borna disease, rats were inoculated with different doses of BDV attenuated by culture in MDCK cells. Low doses of attenuated BDV (10(2)-10(4) TCID50) resulted in typical clinical disease and severe encephalitis; however, the lag period between inoculation and disease was considerably longer than that with virulent BDV. In contrast, animals inoculated with a high dose of attenuated BDV (10(5)-10(6) TCID50) did not develop clinical disease, although a mild encephalitic response was present that did not progress beyond the mild encephalitis. Animals inoculated with a high dose of BDV developed high titers of anti-BDV antibody and were protected against virulent challenge. Protection was correlated with the rapid induction of an immune response in the animals and the lack of any biologically detectable virus in the CNS.
No takes yet. Share an insight, caveat, or question.
Oldach et al. (1995) studied Borna disease. High dose of attenuated BDV vs. Low doses of attenuated BDV (10(2)-10(4) TCID50) was evaluated on Clinical disease and protection against virulent challenge. Inoculation with a high dose of attenuated Borna disease virus (10^5-10^6 TCID50) protected rats against clinical disease and virulent challenge, unlike low doses which caused severe encephalitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: